Hemlibra Provides Control of Bleeding in People with or without Factor VIII Inhibitors
Roche’s Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in haemophilia A without factor VIII inhibitors
Roche’s Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in haemophilia A without factor VIII inhibitors
New Yumizen G coagulation analyzers and reagent range designed to suit any laboratory
Which new product, instrument or consumable has made the most difference to your clinical lab or point-of-care practice? Nominate now for a chance to win a $500/£400/450€ Amazon voucher
The new system aims to deliver fast, accurate results through near native-state cellular characterization, precise flagging and a 93% first-pass throughput
The robust, easy-to-use system aims to boost patient care by combining many of the analytic strengths of a larger-volume instrument with the ease of a table-top analyzer
First-of-its-kind hematology-based test intended to alert emergency department clinicians to the risk of developing sepsis
Healthcare wearables company, Activinsights, commended for enterprise in Britain’s top business accolade
The test will expand the range of diagnostic options available to guide the treatment of Plasmodium vivax
SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism
From rhinos to chemical warfare agents, we bring you the latest in forensics and toxicology
Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute
Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research
Study demonstrates that the test can add prognostic information on overall survival
New blood test provides a unique new framework for early detection of the most common cancers
Research by the University of Edinburgh suggests a way to detect the cause of stroke
Flagship exhibition will be held at the Dubai International Convention & Exhibition Centre, Dubai, UAE in February 2018
A new cost-effective, cloud-based middleware solution helps low-volume laboratories streamline processes and minimize costs
Detecting and minimizing pre-analytical variables in clinical analysis